Here is a summary of what was discussed in the webinar we held on 30 June: Dr. Arvind Bagga (Pediatric Nephrologist, Indraprastha Apollo ...

We had an overwhelming response for the first aHUS webinar we held on Monday 30 June. For those who missed it and wish to watch it or if you...

The Atypical HUS India Foundation is hosting its first webinar. This event is for aHUS patients and their families, aiming to simplify the c...

Tell the world your story! The Atypical HUS India Foundation invites patients and their family to record short videos about their story - ho...

If you ask someone what is the number of aHUS patients in India, the only answer you will get are 'guesstimates'. No data exists on ...

Soliris (brand name for the drug Eculizumab from Alexion Pharmaceuticals, now acquired by Astra Zeneca) was finally approved by the Indian ...

  In the first week of October, the Delhi High Court heard several petitions together that were filed by patients afflicted with a rare dise...